{"transactions":[{"id":305898,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022."}],"balance_after":11395,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":335},"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305897,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":4665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":4665},"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305896,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":335,"price":146.26,"value":48997.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305895,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":335,"price":61.35,"value":20552.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10401,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305894,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":26,"price":146.36,"value":3805.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305893,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":26,"price":67.45,"value":1753.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10092,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305892,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1658,"price":145.7286,"value":241618.0188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305891,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1658,"price":67.45,"value":111832.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11724,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305890,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1816,"price":144.9248,"value":263183.4368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305889,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1816,"price":67.45,"value":122489.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11882,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305888,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1165,"price":143.7543,"value":167473.7595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305887,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1165,"price":67.45,"value":78579.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11231,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":310146,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:40:28.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0000882095-26-000010","document":"wk-form4_1777927225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000010/wk-form4_1777927225.xml","form_type":"4"}},{"id":310145,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:40:28.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,146 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0000882095-26-000010","document":"wk-form4_1777927225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000010/wk-form4_1777927225.xml","form_type":"4"}},{"id":315003,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-01-21T21:26:11.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":4665,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001771814-26-000002","document":"wk-form4_1769030768.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000002/wk-form4_1769030768.xml","form_type":"4"}},{"id":315002,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:26:11.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":123.5,"value":617500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":8920,"source":{"system":"sec-edgar","filing":"0001771814-26-000002","document":"wk-form4_1769030768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000002/wk-form4_1769030768.xml","form_type":"4"}},{"id":315001,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:26:11.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":67.45,"value":337250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":13920,"source":{"system":"sec-edgar","filing":"0001771814-26-000002","document":"wk-form4_1769030768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000002/wk-form4_1769030768.xml","form_type":"4"}},{"id":316652,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-12-01T23:11:59.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024."}],"balance_after":7648,"derivative":{"exercise_price":64.92,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001771814-25-000005","document":"wk-form4_1764630716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181425000005/wk-form4_1764630716.xml","form_type":"4"}},{"id":316651,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T23:11:59.000Z","date":"2025-11-28","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":125.08,"value":625400.0,"ownership":{"direct":true},"balance_after":8920,"source":{"system":"sec-edgar","filing":"0001771814-25-000005","document":"wk-form4_1764630716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181425000005/wk-form4_1764630716.xml","form_type":"4"}},{"id":316650,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T23:11:59.000Z","date":"2025-11-28","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":64.92,"value":324600.0,"ownership":{"direct":true},"balance_after":13920,"source":{"system":"sec-edgar","filing":"0001771814-25-000005","document":"wk-form4_1764630716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181425000005/wk-form4_1764630716.xml","form_type":"4"}},{"id":320709,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-07-15T19:59:27.000Z","date":"2025-07-14","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":9665,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-25-019182","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019182/form4.xml","form_type":"4"}},{"id":320708,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-15T19:59:27.000Z","date":"2025-07-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":109.74,"value":548700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":8920,"source":{"system":"sec-edgar","filing":"0001127602-25-019182","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019182/form4.xml","form_type":"4"}},{"id":320707,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-15T19:59:27.000Z","date":"2025-07-14","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":67.45,"value":337250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025."}],"balance_after":13920,"source":{"system":"sec-edgar","filing":"0001127602-25-019182","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225019182/form4.xml","form_type":"4"}},{"id":322393,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-05-09T00:16:09.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":6809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025."}],"balance_after":6809,"derivative":{"exercise_price":98.9,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":6809},"source":{"system":"sec-edgar","filing":"0001127602-25-013771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225013771/form4.xml","form_type":"4"}},{"id":322392,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2025-05-09T00:16:09.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":1516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 7, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 7, 2025."}],"balance_after":5713,"derivative":{"underlying":"Common Stock","underlying_shares":1516},"source":{"system":"sec-edgar","filing":"0001127602-25-013771","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225013771/form4.xml","form_type":"4"}},{"id":328887,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-11-27T23:14:41.000Z","date":"2024-11-26","kind":"exercise","planned":false,"acquired":false,"shares":4121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022."}],"balance_after":11730,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":4121},"source":{"system":"sec-edgar","filing":"0001127602-24-028213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028213/form4.xml","form_type":"4"}},{"id":328886,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-11-27T23:14:41.000Z","date":"2024-11-26","kind":"exercise","planned":false,"acquired":false,"shares":5879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021."}],"balance_after":0,"derivative":{"exercise_price":61.17,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":5879},"source":{"system":"sec-edgar","filing":"0001127602-24-028213","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028213/form4.xml","form_type":"4"}},{"id":328885,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-27T23:14:41.000Z","date":"2024-11-26","kind":"sale","planned":false,"acquired":false,"shares":6788,"price":91.3901,"value":620355.9988,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Sale prices reported for the transactions reported here range from $91.3901 to $91.3910.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":8920,"source":{"system":"sec-edgar","filing":"0001127602-24-028213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028213/form4.xml","form_type":"4"}},{"id":328884,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-27T23:14:41.000Z","date":"2024-11-26","kind":"exercise","planned":false,"acquired":true,"shares":4121,"price":61.35,"value":252823.35,"ownership":{"direct":true},"balance_after":15708,"source":{"system":"sec-edgar","filing":"0001127602-24-028213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028213/form4.xml","form_type":"4"}},{"id":328883,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-27T23:14:41.000Z","date":"2024-11-26","kind":"exercise","planned":false,"acquired":true,"shares":5879,"price":61.17,"value":359618.43,"ownership":{"direct":true},"balance_after":11587,"source":{"system":"sec-edgar","filing":"0001127602-24-028213","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224028213/form4.xml","form_type":"4"}},{"id":333997,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2024-05-09T21:08:35.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":12648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024."}],"balance_after":12648,"derivative":{"exercise_price":64.92,"expiration_date":"2034-05-08","underlying":"Common Stock","underlying_shares":12648},"source":{"system":"sec-edgar","filing":"0001127602-24-014809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224014809/form4.xml","form_type":"4"}},{"id":333996,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2024-05-09T21:08:35.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":2310,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 8, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 8, 2024."}],"balance_after":4197,"derivative":{"underlying":"Common Stock","underlying_shares":2310},"source":{"system":"sec-edgar","filing":"0001127602-24-014809","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760224014809/form4.xml","form_type":"4"}},{"id":349446,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2023-05-04T22:13:30.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":10173,"price":79.45,"value":808244.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023."}],"balance_after":10173,"derivative":{"exercise_price":79.45,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":10173},"source":{"system":"sec-edgar","filing":"0001127602-23-014562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223014562/form4.xml","form_type":"4"}},{"id":349445,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-05-04T22:13:30.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":1887,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested immediately upon the grant date of May 3, 2023."}],"balance_after":1887,"derivative":{"underlying":"Common Stock","underlying_shares":1887},"source":{"system":"sec-edgar","filing":"0001127602-23-014562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760223014562/form4.xml","form_type":"4"}},{"id":2265759,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-18T18:02:54.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 17, 2023."}],"balance_after":33000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-05-17","underlying":"Common Stock, par value $0.0001","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001493152-22-014361","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315222014361/ownership.xml","form_type":"4"}},{"id":361731,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2022-05-06T22:57:57.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":15851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022."}],"balance_after":15851,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":15851},"source":{"system":"sec-edgar","filing":"0001127602-22-013726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013726/form4.xml","form_type":"4"}},{"id":361730,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-06T22:57:57.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":2444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 2,444 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.  The RSUs vested immediately upon the grant date of May 5, 2022."}],"balance_after":5708,"source":{"system":"sec-edgar","filing":"0001127602-22-013726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013726/form4.xml","form_type":"4"}},{"id":361944,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2022-05-04T00:17:44.000Z","date":"2022-05-03","kind":"exercise","acquired":false,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested on May 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001127602-22-013129","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013129/form4.xml","form_type":"4"}},{"id":361943,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-04T00:17:44.000Z","date":"2022-05-03","kind":"exercise","acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":3264,"source":{"system":"sec-edgar","filing":"0001127602-22-013129","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760222013129/form4.xml","form_type":"4"}},{"id":368722,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-12-09T18:15:53.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units vested on December 8, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units vested on December 8, 2021."}],"balance_after":2223,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001127602-21-030577","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221030577/form4.xml","form_type":"4"}},{"id":368721,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-12-09T18:15:53.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":1041,"source":{"system":"sec-edgar","filing":"0001127602-21-030577","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221030577/form4.xml","form_type":"4"}},{"id":375569,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2021-05-14T20:22:28.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":14665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":14665,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":14665},"source":{"system":"sec-edgar","filing":"0001127602-21-016844","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221016844/form4.xml","form_type":"4"}},{"id":375568,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-05-14T20:22:28.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":3264,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001127602-21-016844","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760221016844/form4.xml","form_type":"4"}},{"id":2712404,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-14T19:47:22.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full and become exercisable upon the earlier to occur of (a) the business day before the Issuer's next annual meeting of stockholders and (b) May 12, 2022."}],"balance_after":23000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-05-12","underlying":"Common Stock, par value $0.0001","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001493152-21-011586","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315221011586/ownership.xml","form_type":"4"}},{"id":382980,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-12-10T21:10:21.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vest on December 8, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vest on December 8, 2021."}],"balance_after":1041,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001127602-20-031071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220031071/form4.xml","form_type":"4"}},{"id":382979,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2020-12-10T21:10:21.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":5879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021."}],"balance_after":5879,"derivative":{"exercise_price":61.17,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":5879},"source":{"system":"sec-edgar","filing":"0001127602-20-031071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760220031071/form4.xml","form_type":"4"}},{"id":3081845,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-07-16T18:01:09.000Z","date":"2020-07-15","kind":"grant","acquired":true,"shares":22200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"22,200 option shares vest on July 15, 2021."}],"balance_after":22200,"derivative":{"exercise_price":12.62,"expiration_date":"2030-07-15","underlying":"Common Stock, par value $0.0001","underlying_shares":22200},"source":{"system":"sec-edgar","filing":"0001493152-20-013472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220013472/ownership.xml","form_type":"4"}},{"id":3177262,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-14T17:00:29.000Z","date":"2020-02-27","kind":"gift","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Bluestone Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On February 27, 2020, the reporting person contributed options to purchase up to 24,000 shares of Common Stock to the Bluestone Family Trust as a gift. The option was granted on June 24, 2019, pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option fully vests on May 28, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person, together with his spouse are trustees and the reporting person, his spouse and children are the beneficiaries of the Bluestone Family Trust."}],"balance_after":0,"derivative":{"exercise_price":12.54,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3177261,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-14T17:00:29.000Z","date":"2020-02-27","kind":"gift","acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On February 27, 2020, the reporting person contributed options to purchase up to 24,000 shares of Common Stock to the Bluestone Family Trust as a gift. The option was granted on June 24, 2019, pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option fully vests on May 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":12.54,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3177260,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-14T17:00:29.000Z","date":"2020-04-10","kind":"exercise","acquired":false,"shares":32246,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Bluestone Family Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in eight equal semi-annual installments commencing on September 27, 2019 and will become fully vested on March 27, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person, together with his spouse are trustees and the reporting person, his spouse and children are the beneficiaries of the Bluestone Family Trust."}],"balance_after":96735,"derivative":{"exercise_price":2.36,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":32246},"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3177259,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-14T17:00:29.000Z","date":"2020-02-27","kind":"gift","acquired":true,"shares":128981,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Bluestone Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 27, 2020, the reporting person contributed options to purchase up to 128,981 shares of Common Stock to the Bluestone Family Trust as a gift. The option was granted on March 27, 2019, pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in eight equal semi-annual installments commencing on September 27, 2019 and will become fully vested on March 27, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person, together with his spouse are trustees and the reporting person, his spouse and children are the beneficiaries of the Bluestone Family Trust."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":128981},"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3177258,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-14T17:00:29.000Z","date":"2020-02-27","kind":"gift","acquired":false,"shares":128981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 27, 2020, the reporting person contributed options to purchase up to 128,981 shares of Common Stock to the Bluestone Family Trust as a gift. The option was granted on March 27, 2019, pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in eight equal semi-annual installments commencing on September 27, 2019 and will become fully vested on March 27, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":128981},"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3177257,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock par value $0.0001 per share","published_at":"2020-04-14T17:00:29.000Z","date":"2020-04-10","kind":"exercise","acquired":true,"shares":32246,"price":2.36,"value":76100.56,"ownership":{"direct":false,"nature":"By the Bluestone Family Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 7,325 shares of common stock, par value $0.0001 per share (the \"Common Stock\") previously reported as being owned directly which are owned indirectly by the Bluestone Family Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person, together with his spouse are trustees and the reporting person, his spouse and children are the beneficiaries of the Bluestone Family Trust."}],"balance_after":39571,"source":{"system":"sec-edgar","filing":"0001493152-20-006374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315220006374/ownership.xml","form_type":"4"}},{"id":3478758,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-06-25T16:07:23.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vests on May 28, 2020."}],"balance_after":24000,"derivative":{"exercise_price":12.54,"expiration_date":"2029-06-24","underlying":"Common Stock, par value $0.0001","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-19-009679","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315219009679/ownership.xml","form_type":"4"}},{"id":3487799,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T18:00:12.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":7300,"price":11.93,"value":87089.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.80 to $12.15, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":7325,"source":{"system":"sec-edgar","filing":"0001493152-19-009337","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315219009337/ownership.xml","form_type":"4"}},{"id":3575281,"issuer":{"id":12101,"kind":"organization","name":"Provention Bio, Inc.","symbol":"PRVB"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2019-03-28T17:15:37.000Z","date":"2019-03-27","kind":"grant","acquired":true,"shares":128981,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in eight equal semi-annual installments commencing on September 27, 2019 and will become fully vested on March 27, 2023."}],"balance_after":128981,"derivative":{"exercise_price":2.36,"expiration_date":"2029-03-27","underlying":"Common Stock, par value $0.0001","underlying_shares":128981},"source":{"system":"sec-edgar","filing":"0001493152-19-004128","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695357/000149315219004128/ownership.xml","form_type":"4"}}]}